Adenylate cyclase and insulin action. Effect of insulin, nonsuppressible insulin-like material, and diabetes on adenylate-cyclase activity in mouse liver.
D000255:Adenosine Triphosphate; D000067956:Adenylyl Cyclase Inhibitors; D000262:Adenylyl Cyclases / Q000378:metabolism*; D000818:Animals; D002458:Cell Fractionation; D002462:Cell Membrane / Q000187:drug effects / Q000201:enzymology; D000242:Cyclic AMP; D003920:Diabetes Mellitus / Q000139:chemically induced; D004336:Drug Antagonism; D004789:Enzyme Activation / Q000187:drug effects; D005459:Fluorides / Q000494:pharmacology; D005934:Glucagon / Q000494:pharmacology; D006150:Guanine Nucleotides / Q000494:pharmacology; D007328:Insulin / Q000494:pharmacology*; D008099:Liver / Q000201:enzymology*; D008297:Male; D051379:Mice; D009206:Myocardium / Q000201:enzymology; D010455:Peptides / Q000494:pharmacology*; D010728:Phosphoenolpyruvate; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism; D011955:Receptors, Drug; D012964:Sodium / Q000494:pharmacology; D013311:Streptozocin
D000067956:Adenylyl Cyclase Inhibitors; D006150:Guanine Nucleotides; D007328:Insulin; D010455:Peptides; D011955:Receptors, Drug; D013311:Streptozocin; D010728:Phosphoenolpyruvate; D000255:Adenosine Triphosphate; D005934:Glucagon; D012964:Sodium; D000242:Cyclic AMP; D010727:Phosphoric Diester Hydrolases; D000262:Adenylyl Cyclases; D005459:Fluorides